Tag: pet diabetes care industry analysis

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Pet Diabetes Care Market Value Growth And Long-Term Outlook

The pet diabetes care market has experienced substantial growth in recent times. It will grow from $2.4 billion in 2025 to $2.63 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The expansion observed in the past can be attributed to the increasing occurrence of diabetes in companion animals, the implementation of standard insulin therapies for pets, the growth of veterinary clinic networks, progress in diagnostic instruments for pet diabetes, and a rise in pet ownership.

The pet diabetes care market is projected to experience robust expansion over the coming years. This market is predicted to reach $3.8 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.6%. Factors driving this growth during the forecast period include the advancement of smart insulin delivery devices, the proliferation of home-based monitoring solutions, the increasing use of telemedicine platforms, heightened investment in veterinary endocrinology research, and the expanding availability of species-specific oral medications. Key trends anticipated for the forecast duration encompass the growing acceptance of insulin therapy in pets, the expansion of at-home glucose monitoring for animals, heightened awareness regarding diabetes management in companion animals, the incorporation of telemedicine into pet diabetes care, and the creation of species-specific oral hypoglycemic drugs.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=8095&type=smp&name=Pet%20Diabetes%20Care%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pet Diabetes Care Market Growth Momentum: What Factors Are Shaping Demand?

The increasing need for pet insurance is projected to propel the pet diabetes care market’s expansion in the future. Pet insurance serves as a form of financial security, covering a portion of veterinary expenses for pets and assisting owners in handling healthcare-related costs. The surge in pet insurance adoption stems from rising veterinary treatment costs, prompting owners to seek financial safeguards against unforeseen medical bills and to guarantee prompt care for their animals. Pet diabetes care benefits pet insurance by facilitating prompt diagnosis and ongoing management, which in turn diminishes emergency complications and exorbitant treatment expenses, thereby fostering more consistent and viable insurance claims. For example, in April 2025, data from the North American Pet Health Insurance Association (NAPHIA), a US based pet health insurance trade body, revealed that the count of insured pets across North America climbed to 7.0 million in 2024, marking an increase from 6.25 million in 2023 (representing a 12.2% rise), underscoring the swift growth in demand for pet insurance as owners look for financial protection against escalating veterinary expenditures. Consequently, the rising demand for pet insurance is stimulating the expansion of the pet diabetes care market.

Pet Diabetes Care Market Segment Landscape: Which Areas Lead Development?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin

Pet Diabetes Care Market Trends Redefining Industry Growth

Leading companies in the pet diabetes care market are prioritizing the innovation of technological products, such as the Petrackr diabetes monitoring device, to deliver reliable services to customers. The Petrackr diabetes monitoring device serves as a veterinary blood glucometer, specifically designed for monitoring diabetes in cats and dogs. For example, Universal Biosensors Inc., an Australia-based biosensor company, introduced the Petrackr diabetes monitoring device in May 2023. This device yields blood glucose test results in just seconds and is user-friendly for both pet parents and veterinary clinicians. It integrates with the Petrackr app, allowing users to conveniently record, monitor, and report results.

Pet Diabetes Care Market Key Participants And Competitive Landscape

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

View The Full Pet Diabetes Care Market Report:

https://thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Pet Diabetes Care Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Pet Diabetes Care Market Change Between 2026 And 2030?

The pet diabetes care market size has seen significant growth in recent years. It is anticipated to increase from $2.4 billion in 2025 to $2.63 billion in 2026, with a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to several factors such as the rising prevalence of diabetes in companion animals, the introduction of standard insulin therapies for pets, the expansion of veterinary clinic networks, advancements in diagnostic tools for pet diabetes, and an increase in pet ownership.

The pet diabetes care market is projected for robust expansion over the coming years, with its size expected to reach $3.8 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This anticipated growth throughout the forecast period can be primarily attributed to advancements in smart insulin delivery devices, the expansion of home-based monitoring solutions, increasing adoption of telemedicine platforms, greater investment in veterinary endocrinology research, and the growing availability of species-specific oral medications. Noteworthy trends during this period include a rising adoption of insulin therapy in pets, an increase in at-home glucose monitoring for animals, heightened awareness concerning diabetes management in companion animals, the integration of telemedicine for pet diabetes care, and the development of species-specific oral hypoglycemic drugs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Which Strategic Drivers Are Supporting The Pet Diabetes Care Market Development?

The growing demand for pet insurance is anticipated to drive the growth of the pet diabetes care market going forward. Pet insurance is a type of financial protection that covers some of the veterinary costs associated with caring for pets and helps pet owners manage expenses related to their healthcare needs. Pet insurance is rising because veterinary treatment costs are increasing, making owners seek financial protection to manage unexpected medical expenses and ensure timely care for their pets. Pet diabetes care helps pet insurance by enabling early diagnosis and continuous management that reduces emergency complications and high treatment costs, supporting more predictable and sustainable insurance claims. For instance, in April 2025, according to the North American Pet Health Insurance Association (NAPHIA), a US based pet health insurance trade body, the number of insured pets in North America rose to 7.0 million in 2024, up from 6.25 million in 2023 (a 12.2% increase), highlighting rapidly growing demand for pet insurance as owners seek financial protection against rising veterinary costs. Therefore, the growing demand for pet insurance is driving the growth of the pet diabetes care market.

Which Segment-Based Categories Are Covered In The Pet Diabetes Care Market?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin

Which Trends Are Influencing The Direction Of The Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are focusing on innovating technological products, such as the Petrackr diabetes monitoring device, to provide reliable services to customers. Petrackr diabetes monitoring device is a veterinary blood glucometer designed to monitor diabetes in cats and dogs. For instance, in May 2023, Universal Biosensors Inc., an Australia -based biosensor company launched Petrackr diabetes monitoring device. Petrackr diabetes monitoring device delivers blood glucose test results in just seconds and easy to use for pet parents and veterinary clinicians. it is compatible with the Petrackr app, which allows users to easily record, monitor, and report results.

Which Companies Are Engaged In The Pet Diabetes Care Market Environment?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Pet Diabetes Care Market Report:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Which Region Contributes The Most To The Pet Diabetes Care Market?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Pet Diabetes Care Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Pet Diabetes Care Market Change Between 2026 And 2030?

The pet diabetes care market size has seen significant growth in recent years. It is anticipated to increase from $2.4 billion in 2025 to $2.63 billion in 2026, with a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to several factors such as the rising prevalence of diabetes in companion animals, the introduction of standard insulin therapies for pets, the expansion of veterinary clinic networks, advancements in diagnostic tools for pet diabetes, and an increase in pet ownership.

The pet diabetes care market is projected for robust expansion over the coming years, with its size expected to reach $3.8 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This anticipated growth throughout the forecast period can be primarily attributed to advancements in smart insulin delivery devices, the expansion of home-based monitoring solutions, increasing adoption of telemedicine platforms, greater investment in veterinary endocrinology research, and the growing availability of species-specific oral medications. Noteworthy trends during this period include a rising adoption of insulin therapy in pets, an increase in at-home glucose monitoring for animals, heightened awareness concerning diabetes management in companion animals, the integration of telemedicine for pet diabetes care, and the development of species-specific oral hypoglycemic drugs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Which Strategic Drivers Are Supporting The Pet Diabetes Care Market Development?

The growing demand for pet insurance is anticipated to drive the growth of the pet diabetes care market going forward. Pet insurance is a type of financial protection that covers some of the veterinary costs associated with caring for pets and helps pet owners manage expenses related to their healthcare needs. Pet insurance is rising because veterinary treatment costs are increasing, making owners seek financial protection to manage unexpected medical expenses and ensure timely care for their pets. Pet diabetes care helps pet insurance by enabling early diagnosis and continuous management that reduces emergency complications and high treatment costs, supporting more predictable and sustainable insurance claims. For instance, in April 2025, according to the North American Pet Health Insurance Association (NAPHIA), a US based pet health insurance trade body, the number of insured pets in North America rose to 7.0 million in 2024, up from 6.25 million in 2023 (a 12.2% increase), highlighting rapidly growing demand for pet insurance as owners seek financial protection against rising veterinary costs. Therefore, the growing demand for pet insurance is driving the growth of the pet diabetes care market.

Which Segment-Based Categories Are Covered In The Pet Diabetes Care Market?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin

Which Trends Are Influencing The Direction Of The Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are focusing on innovating technological products, such as the Petrackr diabetes monitoring device, to provide reliable services to customers. Petrackr diabetes monitoring device is a veterinary blood glucometer designed to monitor diabetes in cats and dogs. For instance, in May 2023, Universal Biosensors Inc., an Australia -based biosensor company launched Petrackr diabetes monitoring device. Petrackr diabetes monitoring device delivers blood glucose test results in just seconds and easy to use for pet parents and veterinary clinicians. it is compatible with the Petrackr app, which allows users to easily record, monitor, and report results.

Which Companies Are Engaged In The Pet Diabetes Care Market Environment?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Pet Diabetes Care Market Report:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Which Region Contributes The Most To The Pet Diabetes Care Market?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Pet Diabetes Care Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Anticholinergic Drugs Market Over The 2026–2030 Period?

The pet diabetes care market has experienced significant expansion in recent years. It is forecast to rise from $2.4 billion in 2025 to $2.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. The market’s historical growth can be attributed to the increasing prevalence of diabetes among companion animals, the development of standard insulin therapies for pets, the growth of veterinary clinic infrastructures, advances in diagnostic tools for pet diabetes, and an increase in pet ownership.

The pet diabetes care market size is projected to experience substantial growth in the upcoming years. It is forecast to grow to $3.8 billion in 2030, achieving a compound annual growth rate (CAGR) of 9.6%. The expansion anticipated during the forecast period can be attributed to the advancement of smart insulin delivery devices, the broadening of home-based monitoring solutions, an increase in the adoption of telemedicine platforms, greater investment in veterinary endocrinology research, and the expanding availability of species-specific oral medications. Prominent trends expected in this period include a rising uptake of insulin therapy in pets, the development of at-home glucose monitoring for animals, heightened awareness of diabetes management in companion animals, the integration of telemedicine for pet diabetes care, and the creation of species-specific oral hypoglycemic drugs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

What Drivers Are Expected To Influence The Anticholinergic Drugs Market During The Forecast Period?

The pet diabetes care market is projected to expand due to the increasing demand for pet insurance. Pet insurance provides financial security, covering a portion of veterinary expenses for pets and assisting owners with healthcare costs. The surge in pet insurance adoption stems from escalating veterinary treatment expenses, prompting owners to seek financial safeguards against unforeseen medical bills and to guarantee prompt care for their animals. Pet diabetes care benefits pet insurance by facilitating early detection and ongoing management, thereby minimizing emergency complications and costly treatments, which leads to more stable and sustainable insurance claims. For example, in April 2025, data from the North American Pet Health Insurance Association (NAPHIA), a US-based pet health insurance trade organization, showed that the number of insured pets in North America reached 7.0 million in 2024, an increase from 6.25 million in 2023 (a 12.2% rise). This data underscores the rapid growth in pet insurance demand as owners look for financial protection against rising veterinary costs. Consequently, the increasing need for pet insurance is fueling the growth of the pet diabetes care market.

How Is The Anticholinergic Drugs Market Segmented Across Key Categories?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin

Which Upcoming Trends Are Expected To Influence The Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are concentrating on innovating technological products, such as the Petrackr diabetes monitoring device, to provide reliable services to customers. The Petrackr diabetes monitoring device functions as a veterinary blood glucometer specifically designed to monitor diabetes in cats and dogs. For instance, in May 2023, Universal Biosensors Inc., an Australia-based biosensor company, launched the Petrackr diabetes monitoring device. This device delivers blood glucose test results in just seconds and is easy for pet parents and veterinary clinicians to utilize. It is also compatible with the Petrackr app, which enables users to easily record, monitor, and report results.

Who Are The Dominant Players Shaping The Anticholinergic Drugs Market Landscape?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

Read the full pet diabetes care market report here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Which Region Is Forecast To Lead The Anticholinergic Drugs Market In Terms Of Market Size?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anticholinergic Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

Browse Through More Reports Similar to the Global Pet Diabetes Care Market 2026, By The Business Research Company

Pet Diabetes Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Diabetes Care Devices Market 2026

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Continuous Glucose Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the coconut charcoal briquettes market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Pet Diabetes Care Market by the end of 2030?

The pet diabetes care market has experienced robust growth over recent years. Projections indicate it will expand from $2.4 billion in 2025 to $2.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. This historical expansion can be linked to factors such as an increasing incidence of diabetes among companion animals, the availability of standard insulin treatments for pets, the expansion of veterinary clinic infrastructures, enhancements in diagnostic technologies for pet diabetes, and a rise in pet ownership.

The pet diabetes care market is projected to experience robust expansion in the coming years. By 2030, this market is anticipated to reach $3.8 billion, demonstrating a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period is largely due to several factors, including the creation of intelligent insulin delivery systems, the broadening of in-home monitoring options, the increasing uptake of telemedicine services, a rise in funding for veterinary endocrinology studies, and the wider availability of oral drugs tailored for specific animal species. Key trends expected during this period involve a greater acceptance of insulin treatment for pets, an increase in at-home glucose tracking for animals, heightened understanding of diabetes management among companion animals, the incorporation of telemedicine into pet diabetes treatment, and the creation of oral hypoglycemic medications specific to different species.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

What Drivers Are Shaping Future Opportunities In The Pet Diabetes Care Market?

The escalating need for pet insurance is projected to propel the expansion of the pet diabetes care market moving forward. Pet insurance functions as a form of financial safeguard, covering a portion of veterinary expenses associated with pet care and assisting pet owners in managing their healthcare expenditures. The prevalence of pet insurance is increasing due to rising veterinary treatment costs, prompting owners to seek financial protection to handle unforeseen medical expenses and ensure prompt care for their pets. Pet diabetes care supports pet insurance by facilitating early diagnosis and continuous management, which diminishes emergency complications and high treatment costs, thereby leading to more predictable and sustainable insurance claims. For instance, in April 2025, the North American Pet Health Insurance Association (NAPHIA), a US-based pet health insurance trade body, indicated that the population of insured pets in North America climbed to 7.0 million in 2024, an increase from 6.25 million in 2023 (a 12.2% surge), underscoring the swift growth in demand for pet insurance as owners seek financial security against escalating veterinary costs. Thus, the increasing demand for pet insurance is stimulating the growth of the pet diabetes care market.

Which Segment Groups Are Influencing The Pet Diabetes Care Market?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin

How Are New Market Trends Shaping The Landscape Of The Pet Diabetes Care Market?

Leading companies within the pet diabetes care market are concentrating on developing innovative technological solutions, exemplified by products like the Petrackr diabetes monitoring device, to offer dependable services to consumers. The Petrackr diabetes monitoring device functions as a veterinary blood glucometer, specifically designed for tracking diabetes in feline and canine companions. For example, Universal Biosensors Inc., an Australian biosensor firm, introduced this device in May 2023. It provides blood glucose test results quickly, in mere seconds, and offers ease of use for both pet owners and veterinary professionals. Furthermore, its compatibility with the Petrackr app enables users to effortlessly log, track, and share results.

Who Are The Major Companies Operating In The Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Pet Diabetes Care Market?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pet Diabetes Care Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

Browse Through More Reports Similar to the Global Pet Diabetes Care Market 2026, By The Business Research Company

Pet Diabetes Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Diabetes Care Devices Market 2026

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Continuous Glucose Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the pet diabetes care market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Pet Diabetes Care Market Now And By 2029?

The scope of the pet diabetes care sector has experienced considerable expansion lately, projected to increase from a valuation of $2.21 billion in 2024 to $2.4 billion by 2025, reflecting an annual compounded growth rate of 8.6%. This notable upward trend throughout the past period stems from several factors, including heightened consciousness regarding animal well-being, progress in veterinary science, the rising incidence of diabetes among companion animals, the tendency to treat pets more like family members, intensified attention to specialized pet diets, promotional efforts by veterinary bodies, and enhanced accessibility to insulin and various pharmaceutical treatments.

Anticipated robust expansion heralds a promising future for the domain of pet diabetes care, projecting a market valuation of $3.46 billion by the year 2029, underpinned by a compound annual growth rate of 9.5% across the projection timeframe. This upward trajectory is fueled by several contributing factors, such as the increasing uptake of pet insurance policies, the development of tailored diabetes management strategies for animals, a greater emphasis on proactive pet wellness initiatives, the worldwide spread of pet health concepts, augmented capital flowing into veterinary health studies, and growing disposable incomes among pet owners. Key developments characterizing this period involve progress in diagnostic tools for animal health, heightened attention towards managing pet weight issues, novel developments in administering insulin to pets, broader accessibility of pet insurance benefits, greater dispersal of specialized dietary products for pets, the implementation of telehealth services and remote patient oversight, alongside deepening partnerships within the field of veterinary science.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

Which Long-Term Drivers Are Expected To Sustain The Pet Diabetes Care Market?

The escalating trend of individuals choosing to adopt companion animals, a practice involving securing a pet from a rescue organization or shelter rather than purchasing one from a retail outlet, breeder, or private party, is anticipated to be a major catalyst for the expansion of the pet diabetes care sector in the future. A growing prevalence of diabetes diagnoses among animals, partly attributed to their increasingly sedentary lives and greater consumption of manufactured food products paralleling human habits, is a notable concern. Illustratively, data from Animal Medicines Australia, an Australian-based NGO, showed a substantial rise in pet retention in 2022 reaching 28,730.8 figures, compared to 39% in 2021, representing a substantial 24% leap forward, which clearly indicates a firm upward trajectory in both acquiring pets and allocating resources toward their well-being, underscoring pets’ rising significance within Australian homes and consequently fueling the demand within the pet diabetes management industry.

How Is The Pet Diabetes Care Market Classified By Different Segments?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

What Current And Upcoming Trends Are Shaping The Pet Diabetes Care Market?

A notable upward trend propelling the pet diabetes market involves heightened investment in research and development alongside the introduction of novel offerings. Significant scientific investigations are presently underway concerning animal diabetes, aiming to deepen comprehension of the ailment and simplify its ongoing care. Furthermore, various firms are introducing fresh inventory, including bioequivalent medications, as a means to solidify their standing within this sector. Illustratively, in December 2022, the United States’ Food and Drug Administration, functioning as a governmental scientific oversight body, granted authorization for a product developed by Elanco Animal Health Incorporated, specifically targeting feline diabetes of a particular nature, marking this as the initial orally administered treatment sanctioned for this animal ailment.

Who Are The Primary Market Leaders In The Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Pet Diabetes Care Market?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

Browse Through More Reports Similar to the Global Pet Diabetes Care Market 2025, By The Business Research Company

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Pet Diabetes Care Market Covering 2025–2034?

The pet diabetes care market size has demonstrated significant expansion in recent years. This market is expected to rise from $2.21 billion in 2024 to $2.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.6%. Historically, this growth can be attributed to an increasing awareness of pet health, progress in veterinary medicine, the widespread occurrence of diabetes in pets, the trend of humanizing pets, a greater emphasis on pet nutrition, educational campaigns by veterinary organizations, and the ready availability of insulin and various medications.

The pet diabetes care market is projected for robust expansion over the coming years, with its size anticipated to reach $3.46 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is attributed to several factors, including an increase in pet insurance adoption, the implementation of customized diabetes management plans, a greater emphasis on preventive pet healthcare, the globalization of pet health trends, escalating investments in pet healthcare research, and rising consumer affluence. Significant trends expected in the forecast period encompass advancements in veterinary diagnostics, a dedicated focus on pet obesity management, ongoing innovation in insulin delivery systems, a rise in pet insurance coverage, enhanced availability of specialized pet foods, the adoption of telemedicine and remote monitoring solutions, and strengthened collaborations within veterinary medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Pet Diabetes Care Industry?

A rise in pet adoption is projected to stimulate the expansion of the pet diabetes care market moving forward. Pet adoption involves acquiring a companion animal from a shelter or rescue that has been left behind by its prior owners, as opposed to purchasing one from a pet store, breeder, or other individuals. The diagnosis of diabetes in pets is becoming more frequent each year, partly due to their lifestyles mirroring human ones, characterized by increased inactivity and reliance on processed diets. For instance, in 2022, Animal Medicines Australia, an Australian non-governmental organization, reported substantial growth in pet ownership, with the number of pet owners reaching 28,730.8 in 2022, an increase from 39% in 2021. This indicates a 24% increase, demonstrating a strong upward trend in pet adoption and investment in care. The surge in pet ownership highlights the growing popularity of pets within Australian households. Consequently, the rising rate of pet adoption is fostering the growth of the pet diabetes care market.

What Are The Major Segments Identified In The Pet Diabetes Care Market?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

What Trends Are Redefining The Pet Diabetes Care Market Dynamics?

The pet diabetes market is experiencing significant trends driven by increased research and development activities and the launch of new products. Extensive studies are being conducted on diabetes in animals to better understand the condition and facilitate its management. Moreover, companies are introducing novel products, such as generic drugs, to maintain their market position. In December 2022, the U.S. Food and Drug Administration (FDA), a scientific regulatory agency, approved a medication from Elanco Animal Health Inc. for cats with a specific type of diabetes, making it the first oral treatment authorized for the condition in animals.

Which Leading Companies Dominate The Pet Diabetes Care Market Share?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

What Regional Growth Trends Are Shaping The Pet Diabetes Care Market Outlook?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pet Diabetes Care Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

Browse Through More Reports Similar to the Global Pet Diabetes Care Market 2025, By The Business Research Company

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Pet Diabetes Care Market Through 2034?

The market size for pet diabetes care has consistently seen robust growth in the past few years. It is set to expand from a significant $2.21 billion in 2024 to $2.4 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.6%. The expansion during the historical period can be credited to factors such as increased awareness about pet health, advancements in the field of veterinary medicine, rising instances of diabetes among pets, humanization of pets, heightened focus on pet nutrition, awareness initiatives undertaken by veterinary organizations, and the availability of insulin and other medications.

The market size for pet diabetes care is anticipated to witness robust growth in the coming years. It is projected to expand to $3.46 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. The growth during the predicted period can be credited to factors like the rising adoption of pet insurance, tailored diabetes management plans, emphasis on preventive pet healthcare, the globalization of pet health practices, increased funding in pet health studies, and the growth of consumer affluence. Noteworthy trends during the forecast period encompass progress in veterinary diagnostics, attention on pet obesity control, advancements in insulin delivery systems, growth in pet insurance options, improved accessibility of specialty pet foods, the use of telemedicine and remote monitoring, as well as collaborations within the veterinary medicine field.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Pet Diabetes Care Market?

The anticipated rise in pet adoption is predicted to drive the pet diabetes care market’s expansion. Pet adoption, which involves acquiring a pet from a shelter or rescue that its previous owners have abandoned rather than purchasing one from a pet shop, breeder, or other people, is becoming more prevalent. The fact that pets are being diagnosed with diabetes at an increasing rate each year is partly due to the reflection of our own lifestyles – they tend to be less physically active and rely heavily on processed foods. For instance, in 2022 Animal Medicines Australia, a non-governmental organization in Australia, documented considerable growth in pet ownership. The number of pet owners amounted to 28,730.8 in 2022, growing by 24% from 39% in 2021. This sharp increase underscores the escalating trend in pet adoption and investment in their well-being. The rise in pet ownership emphasizes the growing fondness for pets in Australian families. Hence, the upward swing in pet adoption is fueling the expansion of the pet diabetes care market.

Which Primary Segments of the Pet Diabetes Care Market Are Driving Growth and Industry Transformations?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Pet Diabetes Care Market?# Market?

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Pet Diabetes Care Market?

The rise in research and development activities, along with the introduction of new products, is becoming increasingly important in the pet diabetes market. There is a growing number of studies focused on better understanding diabetes in pets and simplifying its management. Furthermore, to maintain their market standing, companies are debuting new items like generic drugs. For instance, in December 2022, Elanco Animal Health Inc. received approval from the U.S. Food and Drug Administration (FDA) for their medication designed for cats suffering from a particular type of diabetes, marking it as the first FDA-approved oral medication for this condition in animals.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

What Parameters Are Used to Define the Pet Diabetes Care Market?

Pet diabetes care is used to treat pets suffering from diabetes, which may also cause other diseases such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes develops when a pet’s body produces insufficient insulin, stops generating it altogether, or uses it improperly, which hinders the body from converting food into energy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Current and Projected Market Size of the Pet Diabetes Care Market Through 2034?#_x000D_

The market size for pet diabetes care has consistently seen robust growth in the past few years. It is set to expand from a significant $2.21 billion in 2024 to $2.4 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.6%. The expansion during the historical period can be credited to factors such as increased awareness about pet health, advancements in the field of veterinary medicine, rising instances of diabetes among pets, humanization of pets, heightened focus on pet nutrition, awareness initiatives undertaken by veterinary organizations, and the availability of insulin and other medications._x000D_

_x000D_

The market size for pet diabetes care is anticipated to witness robust growth in the coming years. It is projected to expand to $3.46 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. The growth during the predicted period can be credited to factors like the rising adoption of pet insurance, tailored diabetes management plans, emphasis on preventive pet healthcare, the globalization of pet health practices, increased funding in pet health studies, and the growth of consumer affluence. Noteworthy trends during the forecast period encompass progress in veterinary diagnostics, attention on pet obesity control, advancements in insulin delivery systems, growth in pet insurance options, improved accessibility of specialty pet foods, the use of telemedicine and remote monitoring, as well as collaborations within the veterinary medicine field._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the Pet Diabetes Care Market?#_x000D_

The anticipated rise in pet adoption is predicted to drive the pet diabetes care market’s expansion. Pet adoption, which involves acquiring a pet from a shelter or rescue that its previous owners have abandoned rather than purchasing one from a pet shop, breeder, or other people, is becoming more prevalent. The fact that pets are being diagnosed with diabetes at an increasing rate each year is partly due to the reflection of our own lifestyles – they tend to be less physically active and rely heavily on processed foods. For instance, in 2022 Animal Medicines Australia, a non-governmental organization in Australia, documented considerable growth in pet ownership. The number of pet owners amounted to 28,730.8 in 2022, growing by 24% from 39% in 2021. This sharp increase underscores the escalating trend in pet adoption and investment in their well-being. The rise in pet ownership emphasizes the growing fondness for pets in Australian families. Hence, the upward swing in pet adoption is fueling the expansion of the pet diabetes care market._x000D_

_x000D_

#Which Primary Segments of the Pet Diabetes Care Market Are Driving Growth and Industry Transformations?#_x000D_

The pet diabetes care market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Insulin Therapy, Oral Medication _x000D_

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices _x000D_

3) By Animal Type: Canine, Feline, Other Animal Types _x000D_

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals_x000D_

_x000D_

Subsegments:_x000D_

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices_x000D_

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Pet Diabetes Care Market?# Market?#_x000D_

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Most Significant Market Trends in the Pet Diabetes Care Market?#_x000D_

The rise in research and development activities, along with the introduction of new products, is becoming increasingly important in the pet diabetes market. There is a growing number of studies focused on better understanding diabetes in pets and simplifying its management. Furthermore, to maintain their market standing, companies are debuting new items like generic drugs. For instance, in December 2022, Elanco Animal Health Inc. received approval from the U.S. Food and Drug Administration (FDA) for their medication designed for cats suffering from a particular type of diabetes, marking it as the first FDA-approved oral medication for this condition in animals._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Pet Diabetes Care Market?#_x000D_

Pet diabetes care is used to treat pets suffering from diabetes, which may also cause other diseases such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes develops when a pet’s body produces insufficient insulin, stops generating it altogether, or uses it improperly, which hinders the body from converting food into energy._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Current and Projected Market Size of the Pet Diabetes Care Market Through 2034?#_x000D_

The market size for pet diabetes care has consistently seen robust growth in the past few years. It is set to expand from a significant $2.21 billion in 2024 to $2.4 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.6%. The expansion during the historical period can be credited to factors such as increased awareness about pet health, advancements in the field of veterinary medicine, rising instances of diabetes among pets, humanization of pets, heightened focus on pet nutrition, awareness initiatives undertaken by veterinary organizations, and the availability of insulin and other medications._x000D_

_x000D_

The market size for pet diabetes care is anticipated to witness robust growth in the coming years. It is projected to expand to $3.46 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. The growth during the predicted period can be credited to factors like the rising adoption of pet insurance, tailored diabetes management plans, emphasis on preventive pet healthcare, the globalization of pet health practices, increased funding in pet health studies, and the growth of consumer affluence. Noteworthy trends during the forecast period encompass progress in veterinary diagnostics, attention on pet obesity control, advancements in insulin delivery systems, growth in pet insurance options, improved accessibility of specialty pet foods, the use of telemedicine and remote monitoring, as well as collaborations within the veterinary medicine field._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the Pet Diabetes Care Market?#_x000D_

The anticipated rise in pet adoption is predicted to drive the pet diabetes care market’s expansion. Pet adoption, which involves acquiring a pet from a shelter or rescue that its previous owners have abandoned rather than purchasing one from a pet shop, breeder, or other people, is becoming more prevalent. The fact that pets are being diagnosed with diabetes at an increasing rate each year is partly due to the reflection of our own lifestyles – they tend to be less physically active and rely heavily on processed foods. For instance, in 2022 Animal Medicines Australia, a non-governmental organization in Australia, documented considerable growth in pet ownership. The number of pet owners amounted to 28,730.8 in 2022, growing by 24% from 39% in 2021. This sharp increase underscores the escalating trend in pet adoption and investment in their well-being. The rise in pet ownership emphasizes the growing fondness for pets in Australian families. Hence, the upward swing in pet adoption is fueling the expansion of the pet diabetes care market._x000D_

_x000D_

#Which Primary Segments of the Pet Diabetes Care Market Are Driving Growth and Industry Transformations?#_x000D_

The pet diabetes care market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Insulin Therapy, Oral Medication _x000D_

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices _x000D_

3) By Animal Type: Canine, Feline, Other Animal Types _x000D_

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals_x000D_

_x000D_

Subsegments:_x000D_

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices_x000D_

2) By Oral Medication: Glipizide, Metformin, Other Oral Hypoglycemic Agents_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Pet Diabetes Care Market?# Market?#_x000D_

North America was the largest region in the pet diabetes care market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Most Significant Market Trends in the Pet Diabetes Care Market?#_x000D_

The rise in research and development activities, along with the introduction of new products, is becoming increasingly important in the pet diabetes market. There is a growing number of studies focused on better understanding diabetes in pets and simplifying its management. Furthermore, to maintain their market standing, companies are debuting new items like generic drugs. For instance, in December 2022, Elanco Animal Health Inc. received approval from the U.S. Food and Drug Administration (FDA) for their medication designed for cats suffering from a particular type of diabetes, marking it as the first FDA-approved oral medication for this condition in animals._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Pet Diabetes Care Market?#_x000D_

Pet diabetes care is used to treat pets suffering from diabetes, which may also cause other diseases such as heart disease, pancreatitis, urinary tract infections, kidney disease, and skin infections. Diabetes develops when a pet’s body produces insufficient insulin, stops generating it altogether, or uses it improperly, which hinders the body from converting food into energy._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8095_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model